Stryker SYK
NYSE SYK
$298.00 +3.34 (+1.13%)
At close: Oct 19, 2026 · 4:00 PM EDT

Stryker (SYK) Gains from Sales and Divestitures (2009 - 2010)

Updated

Stryker (SYK) recorded Gains from Sales and Divestitures of $23 million in FY2010, compared with -$2.9 million in FY2009.

Analysis

Stryker (SYK) Gains from Sales and Divestitures (2009 - 2010) Analysis & Trends

  • Per Business Quant data, SYK's Gains from Sales and Divestitures was -$2.9 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.93 Bn 230.96 Bn 4.88 Bn
2 Abbott Laboratories 181.29 Bn 151.72 Bn 7.27 Bn
3 Danaher 158.18 Bn 141.99 Bn 3.61 Bn
4 Intuitive Surgical 153.47 Bn 132.89 Bn 1.96 Bn
5 Medtronic 118.97 Bn 84.22 Bn 6.34 Bn
6 Stryker 114.72 Bn 100.84 Bn 4.50 Bn
7 Boston Scientific 66.18 Bn 60.95 Bn 3.85 Bn
8 Becton Dickinson 52.49 Bn 49.64 Bn 2.32 Bn
9 Edwards Lifesciences 50.32 Bn 34.33 Bn 1.35 Bn
10 Agilent Technologies 47.87 Bn 40.76 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 24.00 Mn
Dec 31, 2009 -1.70 Mn
Sep 30, 2009 -700,000.00
API Access

Stryker Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SYK&period=max&api_key=YOUR_API_KEY